Number needed to treat and costs per responder among biologic treatments for moderate-to-severe plaque psoriasis in Japan.

CONCLUSION: Adalimumab 40mg/80mg and secukinumab 150mg/300mg were the most efficacious and cost-efficient for patients with psoriasis in Japan. PMID: 28608740 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28608740?dopt=Abstract

Source: Journal of Dermatological Treatment - June 15, 2017 Category: Dermatology Tags: J Dermatolog Treat Source Type: research